Sphere Fluidics Cyto-Mine® Chroma

The Cyto-Mine® Chroma from Sphere Fluidics is an integrated platform designed for single-cell analysis, monoclonality verification, and targeted antibody discovery. This automated device can offering high-throughput screening capabilities for biologics discovery and cell line development.

Using patented picodroplet technology, the Cyto-Mine® Chroma encapsulates individual cells in picolitre-sized droplets, allowing for precise isolation and analysis. This technology is fully compliant with FDA regulatory requirements for the biopharmaceutical industry.

The Cyto-Mine® Chroma incorporates image-based sorting for fluorescent and absorbance signals, allowing the selection of high-value cells based on multiple parameters such as secreted antibodies or cell-surface markers. Its integrated workflow spans cell isolation, assay, sorting, and deposition in a single system, reducing the need for manual intervention and lowering the risk of contamination.

This system is ideal for research and development teams in fields like therapeutic antibody production, where efficiency and accuracy are critical. Cyto-Mine® Chroma supports labs looking to minimize hands-on time while ensuring data integrity, with a quick processing time for typical screening runs. Additionally, it significantly reduces the space and resources needed for traditional workflows by combining multiple tasks into one device.